NATIONAL HEART, LUNG, AND BLOOD ANNOUNCES INACTIVATION OF PROGRAM ANNOUNCEMENTS
Release Date: December 13, 1999
NOTICE: HL-00-003
National Institute of Heart, Lung, and Blood
The National Heart, Lung, and Blood Institute (NHLBI) regularly reviews its
portfolio of active program announcements. When the objectives of PAs have
been attained, NHLBI announces inactivation of those PAs.
NHLBI supports highly scientifically meritorious applications in all areas of
research within its mission. Except when otherwise noted below, PA
inactivation simply means that special consideration for funding beyond normal
paylines will NO LONGER be given to applications on the research topics
identified in the inactivated PAs. However, such applications will be
accepted, reviewed, and considered for funding according the usual procedures.
At any time, potential applicants can obtain a current listing of active NHLBI
PAs on the NHLBI www site at URL:
http://www.nhlbi.nih.gov/funding/inits/index.htm.
INACTIVATIONS. The following program announcements (Pas) are being
inactivated; NHLBI will no longer give special consideration for funding to
applications in response to these PAs. This notice is effective immediately
and applies to the application receipt deadlines of July 1, 2000 and after.
PA-93-042 Cytokines and Adhesion in Allergy and Inflammation
PA-95-075 Transit from Cardiac Hypertrophy to Overt Heart Failure
PAR-98-009 Supplements for Embryonic Cryoperservation of Rats In
Hypertension Research
INQUIRIES
For questions or further information, contact:
Office of the Director
Division of Extramural Activities
National Heart, Lung, and Blood Institute
Rockledge II, Room 7100
Bethesda, Maryland 20892-7922
Telephone: (301) 435-0260
FAX: (301) 480-4754
[email protected]
Return to NIH Guide Main Index
|
Office of Extramural Research (OER) |
|
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
|
Department of Health and Human Services (HHS) |
|
||||